Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOVIE INC.BIVI · Entity 7702 | Director | January 05, 2026 | January 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOVIE INC.
Report date January 05, 2026 · Filed January 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.31 · Expires 2031-01-05 | Direct | 70,000 |
Reported balance
After 2026-01-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-05 · Grant · Acquired 70,000 · Balance 70,000 F1: The options vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.31 · Expires 2031-01-05 | Direct | 141,100 |
Reported balance
After 2026-01-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-05 · Grant · Acquired 141,100 · Balance 141,100 F2: 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.
F2: 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2026 Filed Jan 9, 2026 17:02 UTC | BIOVIE INC. BIVI · Entity 7702 | GrantStock Option (right to buy) · Derivative | 141,100 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000022 · ownership.xml · derivative · entry 2 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,100 Underlying: Common Stock · 141,100 shares Expires 2031-01-05 F2 · derivative.exercise_date: 75% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029. Read SEC document |
| January 05, 2026 Filed Jan 9, 2026 17:02 UTC | BIOVIE INC. BIVI · Entity 7702 | GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001520138-26-000022 · ownership.xml · derivative · entry 1 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-01-05 F1 · derivative.exercise_date: The options vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting. Read SEC document |
| December 20, 2024 Filed Jan 7, 2025 17:26 UTC | BIOVIE INC. BIVI · Entity 7702 | GrantStock Option (right to buy) · Derivative | 22,070 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001520138-25-000026 · ownership.xml · derivative · entry 2 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,070 Underlying: Common Stock · 22,070 shares Expires 2029-12-20 F2 · derivative.exercise_date: The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026. Read SEC document |
| November 20, 2024 Filed Jan 7, 2025 17:26 UTC | BIOVIE INC. BIVI · Entity 7702 | GrantCommon Stock | 32,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-25-000026 · ownership.xml · nonDerivative · entry 1 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,926 F1 · shares: Represents a restricted stock unit ("RSU") grant, which was approved by the compensation committee of the issuer's board of directors, subject to board approval, which was obtained on November 20, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting. Read SEC document |
| November 09, 2023 Filed Dec 6, 2023 16:16 UTC | BIOVIE INC. BIVI · Entity 7702 | GrantCommon Stock | 42,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001520138-23-000533 · ownership.xml · nonDerivative · entry 1 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,254 F1 · date: The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting. Read SEC document |
| November 23, 2022 Filed Jan 18, 2023 16:55 UTC | BIOVIE INC. BIVI · Entity 7702 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 55,000 | $0.00 Strike: $6.12 | $0.00 |
DisclosureSEC source: 0001520138-23-000062 · ownership.xml · derivative · entry 1 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: COMMON STOCK · 55,000 shares Expires 2032-11-23 F1 · security: Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: The options vest in four equal installments over a one-year period ending November 9, 2023. Read SEC document |
| April 05, 2022 Filed Apr 21, 2022 12:47 UTC | BIOVIE INC. BIVI · Entity 7702 | GrantStock Option (right to buy) · Derivative | 123,400 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001520138-22-000165 · ownership.xml · derivative · entry 1 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,400 Underlying: Common Stock · 123,400 shares Expires 2032-04-05 F1 · security: Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan. F2 · derivative.exercise_date: The options were 25% vested upon grant, with the remaining 75% vesting ratably over a three-year period on each anniversary of the grant date. Read SEC document |
| December 18, 2020 Filed Mar 4, 2021 20:00 UTC | BIOVIE INC. bivi · Entity 7702 | Grantoptions · Derivative | 97,300 | $13.91 Strike: $13.91 | $1,353,443.00 |
DisclosureSEC source: 0001168218-21-000001 · primary_doc.xml · derivative · entry 1 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,300 Underlying: common stock · 97,300 shares Expires 2023-12-18 F1 · security: non-qualified options issued from company 2019 Omnibus Equity Incentive Plan, subject to continuation of service to company F2 · derivative.exercise_date: 25% vest on grant date; remaining 75% vest over 3-year period on 1st, 2nd, 3rd anniversary of grant date Read SEC document |
| June 16, 2020 Filed Nov 16, 2020 15:09 UTC | BIOVIE INC. bivi · Entity 7702 | Othernone | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001168218-20-000002 · primary_doc.xml · nonDerivative · entry 1 ROGICH SIGMUND · CIK 0001168218 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: FORM 3 NOT PREVIOUSLY REPORTED; MR. ROGICH BECAME A DIRECTOR ONLY. NO SECURITIES WERE BENEFICIALLY HELD AT THIS TIME. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.